Dr. Albert Aboseif and Dr. Daniel Bireley, of Cleveland Clinic’s Mellen Center for Multiple Sclerosis, discuss postural orthostatic tachycardia syndrome (POTS), including mechanisms that might contribute to the development of POTS and current immunotherapy research.